Last reviewed · How we verify

NCT03890263

Evaluating Chronic Pain Self-Management Support with an Opioid De-prescribing Intervention

Completed NA Last updated 20 March 2025
What this trial tests

NA trial testing Chronic Pain Self-Management Support in Chronic Pain in 24 participants. Completed in 28 October 2020.

Timeline
1 July 2019
Primary endpoint
28 October 2020
28 October 2020

Quick facts

Lead sponsorQueen's University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment24
Start date1 July 2019
Primary completion28 October 2020
Estimated completion28 October 2020
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Queen's University

Who can join

18 and older, any sex, with Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate the outcomes of the combination of chronic pain self-management support with opioid deprescription, improve our understanding of the experiences and perspectives of patients and healthcare providers with this approach, and determine the characteristics of people on opioids in primary care to inform future research and implementation of this approach

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

Other Queen's University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03890263.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing